Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
Fingolimod protects cultured cortical neurons against excitotoxic death.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome.
Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Fingolimod-Associated Peripheral Vascular Adverse Effects.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Cognitive Impairment in Multiple Sclerosis.
A comparative study of CSF neurofilament light and heavy chain protein in MS.
B Cells in Pregnancy: Functional Promiscuity or Tailored Function?
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Disc swelling and mild initial visual acuity loss predict a better short-term visual acuity outcome in bilateral acute optic neuritis.
[Cost of multiple sclerosis in France.]
Stem cell therapy for central nerve system injuries: glial cells hold the key.
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Pages
« first
‹ previous
…
217
218
219
220
221
222
223
224
225
…
next ›
last »